EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma

María San-Román-Gil iD, Javier Torres-Jiménez iD, Javier Pozas, Jorge Esteban-Villarrubia, Víctor Albarrán-Fernández, Pablo Álvarez-Ballesteros iD, Jesús Chamorro-Pérez, Diana Rosero-Rodríguez, Inmaculada Orejana-Martín, Íñigo Martínez-Delfrade, Pablo Reguera-Puertas, Raquel Fuentes-Mateos und 1 weitere

Cancers · 30.01.2023 · 15 (3) · 863

DOI: 10.3390/cancers15030863 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.01.2023. Verfasst von María San-Román-Gil und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the third most frequent cancer and the second most common cause of cancer-related death in Europe. High microsatellite instability (MSI-H) due to a deficient DNA mismatch repair (dMMR) system can be found in 5% of metastatic CRC (mCRC) and has been established as a biomarker of response to immunotherapy in these tumors. Therefore, immune checkpoint inhibitors (ICIs) in mCRC with these characteristics were evaluated with results showing remarkable response rates and durations of response. The majority of mCRC cases have high levels of DNA mismatch repair proteins (pMMR) with consequent microsatellite stability or low instability (MSS or MSI-low), associated with an inherent resistance to ICIs. This review aims to provide a comprehensive analysis of the possible approaches to overcome the mechanisms of resistance and evaluates potential biomarkers to establish the role of ICIs in pMMR/MSS/MSI-L (MSS) mCRC.

Schlagwörter

Stichwörter der Autor:innen

MSSPOLE/POLD1TMBbiomarkersimmune checkpoint inhibitors (ICI)immunoscoremetastatic colorectal carcinoma (mCRC)microbiomepMMR

Autor:innen und Institutionen

  • Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain.
  • Medical Oncology Department, Clínico San Carlos University Hospital, 28040 Madrid, Spain.
  • Medical Oncology Department, 12 de Octubre University Hospital, 28041 Madrid, Spain.

ORCID-Profile: María San-Román-Gil, Javier Torres-Jiménez, Pablo Álvarez-Ballesteros, Reyes Ferreiro-Monteagudo

Zitieren

APA

San-Román-Gil, M., Torres-Jiménez, J., Pozas, J., Esteban-Villarrubia, J., Albarrán-Fernández, V., Álvarez-Ballesteros, P., Chamorro-Pérez, J., Rosero-Rodríguez, D., Orejana-Martín, I., Martínez-Delfrade, Í., Reguera-Puertas, P., Fuentes-Mateos, R., & Ferreiro-Monteagudo, R. (2023). Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma. Cancers, 15(3), 863. https://doi.org/10.3390/cancers15030863

Vancouver

San-Román-Gil M, Torres-Jiménez J, Pozas J, Esteban-Villarrubia J, Albarrán-Fernández V, Álvarez-Ballesteros P, et al. Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma. Cancers. 2023;15(3):863. doi:10.3390/cancers15030863

BibTeX
@article{SanRomnGil2023,
  author = {San-Román-Gil, María and Torres-Jiménez, Javier and Pozas, Javier and Esteban-Villarrubia, Jorge and Albarrán-Fernández, Víctor and Álvarez-Ballesteros, Pablo and Chamorro-Pérez, Jesús and Rosero-Rodríguez, Diana and Orejana-Martín, Inmaculada and Martínez-Delfrade, Íñigo and Reguera-Puertas, Pablo and Fuentes-Mateos, Raquel and Ferreiro-Monteagudo, Reyes},
  title = {Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {863},
  doi = {10.3390/cancers15030863}
}
Kostenlos starten →